Literature DB >> 21557225

Prognostic molecular biomarkers for cutaneous malignant melanoma.

Ryo Tanaka1, Kazuo Koyanagi, Norihiko Narita, Christine Kuo, Dave S B Hoon.   

Abstract

Molecular signatures of melanoma have propelled new approaches to early diagnosis, monitoring of treatment response, and targeted therapy. This review discusses messenger RNA (mRNA), genomic, and epigenomic melanoma biomarkers in blood and tissue specimens. The major focus is on tissue-based molecular assays to upstage sentinel lymph nodes (SLNs), and blood-based assays to detect melanoma progression by monitoring levels of circulating tumor cells (CTC) and circulating DNA.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21557225      PMCID： PMC3673884          DOI： 10.1002/jso.21969

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN： 0022-4790            Impact factor:   3.454


  91 in total

1.  Detection of circulating melanoma cells by specific amplification of tyrosinase complementary DNA is not a reliable tumor marker in melanoma patients: a clinical two-center study.

Authors:  R Gläser; K Rass; S Seiter; A Hauschild; E Christophers; W Tilgen
Journal:  J Clin Oncol       Date:  1997-08       Impact factor: 44.544

2.  Evaluation of tyrosinase mRNA as a tumor marker in the blood of melanoma patients.

Authors:  F A Jung; A C Buzaid; M I Ross; K V Woods; J J Lee; M Albitar; E A Grimm
Journal:  J Clin Oncol       Date:  1997-08       Impact factor: 44.544

3.  Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients.

Authors:  P J Bostick; D L Morton; R R Turner; K T Huynh; H J Wang; R Elashoff; R Essner; D S Hoon
Journal:  J Clin Oncol       Date:  1999-10       Impact factor: 44.544

4.  Ectopic expression of target genes may represent an inherent limitation of RT-PCR assays used for micrometastasis detection: studies on the epithelial glycoprotein gene EGP-2.

Authors:  H de Graaf; G M Maelandsmo; P Ruud; A Forus; T Oyjord; O Fodstad; E Hovig
Journal:  Int J Cancer       Date:  1997-07-03       Impact factor: 7.396

5.  Microsatellite alterations in serum DNA of head and neck cancer patients.

Authors:  H Nawroz; W Koch; P Anker; M Stroun; D Sidransky
Journal:  Nat Med       Date:  1996-09       Impact factor: 53.440

6.  Assessment of messenger RNA of beta 1-->4-N-acetylgalactosaminyl-transferase as a molecular marker for metastatic melanoma.

Authors:  C T Kuo; P J Bostick; R F Irie; D L Morton; A J Conrad; D S Hoon
Journal:  Clin Cancer Res       Date:  1998-02       Impact factor: 12.531

7.  Detection of K-ras gene mutations in plasma DNA of patients with pancreatic adenocarcinoma: correlation with clinicopathological features.

Authors:  T Yamada; S Nakamori; H Ohzato; S Oshima; T Aoki; N Higaki; K Sugimoto; K Akagi; Y Fujiwara; I Nishisho; M Sakon; M Gotoh; M Monden
Journal:  Clin Cancer Res       Date:  1998-06       Impact factor: 12.531

8.  cDNA cloning of mouse ret proto-oncogene and its sequence similarity to the cadherin superfamily.

Authors:  T Iwamoto; M Taniguchi; N Asai; K Ohkusu; I Nakashima; M Takahashi
Journal:  Oncogene       Date:  1993-04       Impact factor: 9.867

9.  Prognostic significance of allelic losses in primary melanoma.

Authors:  E Healy; C Belgaid; M Takata; D Harrison; N W Zhu; D A Burd; H S Rigby; J N Matthews; J L Rees
Journal:  Oncogene       Date:  1998-04-30       Impact factor: 9.867

10.  Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes.

Authors:  B Gaugler; B Van den Eynde; P van der Bruggen; P Romero; J J Gaforio; E De Plaen; B Lethé; F Brasseur; T Boon
Journal:  J Exp Med       Date:  1994-03-01       Impact factor: 14.307
View more
  7 in total

1.  High Expression of miR-532-5p, a Tumor Suppressor, Leads to Better Prognosis in Ovarian Cancer Both In Vivo and In Vitro.

Authors:  Fan Wang; Jeremy T-H Chang; Chester Jingshiu Kao; R Stephanie Huang
Journal:  Mol Cancer Ther       Date:  2016-02-12       Impact factor: 6.261

Review 2.  Epigenetic biomarkers in skin cancer.

Authors:  Edward S Greenberg; Kelly K Chong; Kelly T Huynh; Ryo Tanaka; Dave S B Hoon
Journal:  Cancer Lett       Date:  2012-01-27       Impact factor: 8.679

Review 3.  Pathways and therapeutic targets in melanoma.

Authors:  Emma Shtivelman; Michael Q A Davies; Patrick Hwu; James Yang; Michal Lotem; Moshe Oren; Keith T Flaherty; David E Fisher
Journal:  Oncotarget       Date:  2014-04-15

4.  Biological properties of acidic cosmetic water from seawater.

Authors:  Wei-Ting Liao; Tsi-Shu Huang; Chien-Chih Chiu; Jian-Liang Pan; Shih-Shin Liang; Bing-Hung Chen; Shi-Hui Chen; Po-Len Liu; Hui-Chun Wang; Zhi-Hong Wen; Hui-Min Wang; Shu-Wen Hsiao
Journal:  Int J Mol Sci       Date:  2012-05-16       Impact factor: 6.208

5.  The Prognostic Value of Circulating Cell-Free DNA in Colorectal Cancer: A Meta-Analysis.

Authors:  Shiva Basnet; Zhen-Yu Zhang; Wen-Qiang Liao; Shu-Heng Li; Ping-Shu Li; Hai-Yan Ge
Journal:  J Cancer       Date:  2016-06-04       Impact factor: 4.207

Review 6.  Recent Developments of Circulating Tumor Cell Analysis for Monitoring Cutaneous Melanoma Patients.

Authors:  Yoshiaki Shoji; Matias A Bustos; Rebecca Gross; Dave S B Hoon
Journal:  Cancers (Basel)       Date:  2022-02-09       Impact factor: 6.639

7.  Transcription factor LSF (TFCP2) inhibits melanoma growth.

Authors:  Yuji Goto; Ichiro Yajima; Mayuko Kumasaka; Nobutaka Ohgami; Asami Tanaka; Toyonori Tsuzuki; Yuji Inoue; Satoshi Fukushima; Hironobu Ihn; Mikiko Kyoya; Hiroyuki Ohashi; Tamihiro Kawakami; Dorothy C Bennett; Masashi Kato
Journal:  Oncotarget       Date:  2016-01-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.